Bayer further expands global incubator network with Bayer Co.Lab Berlin and welcomes MyoPax as first resident

Investment underscores Bayer´s commitment to creating a leading life science ecosystem for innovative therapies in Berlin

02-Dec-2024 - Bayer announced the inauguration of its new life science incubator Bayer Co.Lab Berlin, located on the Global Headquarters Campus of Bayer’s Pharmaceuticals Division, near world-renowned research and clinical institutions. MyoPax GmbH, a Berlin-based start-up company specializing in muscle ...

Side-effect free RNA therapeutics active only in diseased cells

SRTD biotech secures seed financing

18-Nov-2024 - Jülich-based biotech start-up SRTD biotech GmbH has successfully closed a seven-figure seed financing round. The company will use the fresh capital to accelerate the development of novel RNA therapeutics. Based on a proprietary platform technology, SRTD biotech aims to develop highly efficient ...

Collaboration between medac and start-up chiron to develop organ-on-chip technology

Further development and establishment of animal free testing methods for the pharmaceutical industry

12-Nov-2024 - Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods is progressing. In this context the pharmaceutical company medac and the start-up chiron biotechnology are working together on the further ...

QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery

28-Oct-2024 - QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced that the company is entering into a strategic research collaboration with the group of Dr. Johannes Zuber, a world-leading expert in functional genetics and one ...

Innovative approach to treat autism spectrum disorders

University of Basel spin-off Translation-X receives Venture Kick funding

08-Oct-2024 - In 2022, Dr. Özgür Genç together with Professor Peter Scheiffele from the Biozentrum, University of Basel, founded the startup Translation-X with the goal of developing novel therapeutics for autism spectrum disorders. They have now received 150’000 Swiss Francs investment from the Venture Kick ...

€1.3M pre-seed funding for Lucid Genomics

Startup will use funds to fine-tune their AI models for diagnostics and biomarker discovery

05-Sep-2024 - The Berlin-based startup Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and the Institute of Medical Genetics and Human Genetics at the Charité - Universitätsmedizin Berlin, has raised €1.3 million in pre-seed funding in a funding round led by Caesar Ventures, ...

LMU research transfer: several start-ups attract 7-figure investments

In successful funding rounds, three LMU spin-offs have brought in investments worth millions.

25-Jun-2024 - Tubulis, Smart Reporting, and Eisbach Bio have successfully attracted new investor funding. The new capital will enable the companies, for example, to expand their research and development activities. Tubulis and Eisbach develop new therapeutic approaches and active agents for cancer treatment, ...

Biotechnology start-up using AI to translate nature into new medicines

Enveda Biosciences announces $55M in new funding to accelerate platform and advance multiple candidates to clinical trials

19-Jun-2024 - Enveda Biosciences announced a new financing round of $55 million to add to its $119 million combined Series B and B1. New investors Premji Invest, Lingotto Investment Fund, Microsoft, and The Nature Conservancy participated in the round alongside existing investors Kinnevik, True Ventures, FPV, ...

NEOsphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery

16-May-2024 - NEOsphere Biotechnologies GmbH, a German biotechnology company pioneering high-throughput proteomics to systematically build broad and unique portfolios of novel degrader targets at scale, announced a collaboration withKymera Therapeutics, Inc. focused on unlocking undrugged or poorly drugged ...

16th BioVaria honours SurvivX and QUASAR Therapeutics with Startup Pitch & Partner Awards

Among the GO-Bio initial and ForTra projects, Innovade, Cognisa and Mallia Therapeutics were selected as winners

07-May-2024 - The international life-science community gathered last week in Munich for the 16th BioVaria, Europe’s leading showcasing event for breakthrough technologies and start-ups in the field. Organized by 13 technology transfer organizations, the event serves as a catalyst for forging partnerships ...